As shown in Figure 7C, the expression of the TIDE e, exclusive score, CD8, and CD274 scores in BC was lower in the high lactate group than in the low lactate group, i.e., patients in the high lactate group might be more sensitive to the immunotherapy. The gene discussed is CD8A; the disease is breast cancer.